SABSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SABSW
SAB Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.60+0.07 (+2.77%)
Close on Oct 19, 2026
- Market cap
- $207.36M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of SAB Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 13, 2026 | Oct 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2026 | Jul 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2026 | May 4, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 5, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Sep 30, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 26, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 26, 2025 | Aug 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2025 | Jul 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2025 | Jul 17, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 17, 2025 | Jun 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2024 | Sep 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 26, 2024 | Jul 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | May 26, 2024 | May 31, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 22, 2024 | May 30, 2024 | SEC EDGAR |
| Current report | 8-K | May 21, 2024 | May 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 20, 2024 | SEC EDGAR |
| Current report | 8-K | May 3, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 12, 2024 | Apr 15, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2024 | Mar 29, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2024 | Mar 8, 2024 | SEC EDGAR |